Alnylam Pharmaceuticals Inc. is a biopharmaceutical company specializing in RNAi therapeutics. With a focus on rare genetic diseases, the company aims to develop innovative treatments using its proprietary platform. By leveraging RNA interference, Alnylam Pharmaceuticals aims to transform the lives of patients through groundbreaking scientific advancements.
Notification